LABCORP HOLDINGS INC. (LH) — SEC Filings

Latest SEC filings for LABCORP HOLDINGS INC. (LH), explained in plain English.

Sentiment Overview: 2 bullish, 48 neutral

Recent Filings (50)

• Labcorp Holdings Inc. Files 8-K — 8-K · 2025-12-30T00:00:00.000Z [neutral] Risk: low
  Labcorp Holdings Inc. filed an 8-K on December 30, 2025, reporting information under Regulation FD and including financial statements and exhibits. The filing d
• Labcorp Announces Board & Executive Compensation Changes — 8-K · 2025-12-15T00:00:00.000Z [neutral] Risk: low
  Labcorp Holdings Inc. announced on December 9, 2025, changes in its board and executive compensation. Specifically, the company reported the departure of a dire
• 8-K Filing — 8-K · 2025-12-10T00:00:00.000Z [neutral]
• 8-K Filing — 8-K · 2025-11-24T00:00:00.000Z [neutral]
• Labcorp Q3 Earnings Soar 54% on Robust Revenue Growth — 10-Q · 2025-10-31T00:00:00.000Z [bullish] Risk: medium
  Labcorp Holdings Inc. (LH) reported a strong financial performance for the three and nine months ended September 30, 2025. Revenues increased by 8.5% to $3,563.
• Labcorp Holdings Files 8-K on Financials — 8-K · 2025-10-28T00:00:00.000Z [neutral] Risk: low
  Labcorp Holdings Inc. filed an 8-K on October 28, 2025, reporting on its results of operations and financial condition. The filing includes financial statements
• Labcorp Holdings Files 8-K — 8-K · 2025-10-08T00:00:00.000Z [neutral] Risk: low
  On October 7, 2025, LABCORP HOLDINGS INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the submission of Financial Statements
• Labcorp Holdings Files 8-K — 8-K · 2025-09-25T00:00:00.000Z [neutral] Risk: low
  On September 25, 2025, LABCORP HOLDINGS INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits.
• Labcorp Holdings Inc. Files 8-K — 8-K · 2025-08-28T00:00:00.000Z [neutral] Risk: low
  On August 27, 2025, LABCORP HOLDINGS INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No
• Labcorp's Net Income Doubles, EPS Jumps 100% in H1 2025 — 10-Q · 2025-08-01T00:00:00.000Z [bullish] Risk: low
  Labcorp Holdings Inc. reported a net income of $648.5 million for the six months ended June 30, 2025, a significant increase compared to the prior year. Diluted
• Labcorp Holdings Files 8-K on Financials — 8-K · 2025-07-24T00:00:00.000Z [neutral] Risk: low
  Labcorp Holdings Inc. filed an 8-K on July 24, 2025, reporting on its results of operations and financial condition. The filing includes financial statements an
• Labcorp Files 8-K: Regulation FD Disclosure — 8-K · 2025-07-10T00:00:00.000Z [neutral] Risk: low
  Labcorp Holdings Inc. filed an 8-K on July 10, 2025, reporting an event on July 9, 2025. The filing is a current report under Regulation FD and includes financi
• Labcorp Enters Material Agreement, Incurs Financial Obligation — 8-K · 2025-06-27T00:00:00.000Z [neutral] Risk: medium
  On June 27, 2025, LABCORP HOLDINGS INC. entered into a material definitive agreement and incurred a direct financial obligation. The filing does not specify the
• Labcorp Holdings Inc. Files 8-K Report — 8-K · 2025-06-26T00:00:00.000Z [neutral] Risk: low
  On June 26, 2025, LABCORP HOLDINGS INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No sp
• Labcorp Announces Executive Changes and Shareholder Votes — 8-K · 2025-05-20T00:00:00.000Z [neutral] Risk: low
  Labcorp Holdings Inc. announced on May 15, 2025, several key executive changes and compensatory arrangements. The company also reported on matters submitted to
• Labcorp Holdings Inc. Files 8-K — 8-K · 2025-05-08T00:00:00.000Z [neutral] Risk: low
  On May 8, 2025, LABCORP HOLDINGS INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No spec
• Labcorp Holdings Inc. Q1 2025 10-Q Filing — 10-Q · 2025-04-29T00:00:00.000Z [neutral] Risk: low
  Labcorp Holdings Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarte
• Labcorp Holdings Files 8-K — 8-K · 2025-04-10T00:00:00.000Z [neutral] Risk: low
  Labcorp Holdings Inc. filed an 8-K on April 10, 2025, reporting an event on April 9, 2025. The filing is a current report under Regulation FD and includes finan
• Labcorp Files DEF 14A: Executive Compensation Details — DEF 14A · 2025-04-04T00:00:00.000Z [neutral] Risk: low
  Labcorp Holdings Inc. filed its DEF 14A on April 4, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation, stock perform
• Labcorp Holdings Files 8-K — 8-K · 2025-03-31T00:00:00.000Z [neutral] Risk: low
  Labcorp Holdings Inc. filed an 8-K on March 31, 2025, reporting on events as of the same date. The filing primarily concerns Regulation FD Disclosure and Financ
• Labcorp Holdings Inc. Files 2024 10-K — 10-K · 2025-02-25T00:00:00.000Z [neutral] Risk: medium
  Labcorp Holdings Inc. filed its 2024 10-K on February 25, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Laboratory
• Labcorp Holdings Inc. Files 8-K on Financials — 8-K · 2025-02-06T00:00:00.000Z [neutral] Risk: low
  On February 6, 2025, LABCORP HOLDINGS INC. filed an 8-K report detailing results of operations and financial condition. The filing includes financial statements
• Labcorp Holdings Files 8-K on Definitive Agreement — 8-K · 2025-01-31T00:00:00.000Z [neutral] Risk: medium
  On January 31, 2025, LABCORP HOLDINGS INC. filed an 8-K report detailing a material definitive agreement and the creation of a direct financial obligation. The
• Labcorp Holdings Files 8-K — 8-K · 2025-01-10T00:00:00.000Z [neutral] Risk: low
  On January 8, 2025, LABCORP HOLDINGS INC. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and financial statements/exhibits. No spe
• Labcorp Holdings Files 8-K — 8-K · 2025-01-08T00:00:00.000Z [neutral] Risk: low
  On January 8, 2025, LABCORP HOLDINGS INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the filing of Financial Statements and
• Labcorp Announces Board Changes and Officer Appointments — 8-K · 2024-11-19T00:00:00.000Z [neutral] Risk: low
  Labcorp Holdings Inc. announced on November 15, 2024, a change in its board of directors, including the election of new directors and the appointment of certain
• Labcorp Holdings Inc. Files Q3 2024 10-Q Report — 10-Q · 2024-10-29T00:00:00.000Z [neutral] Risk: low
  Labcorp Holdings Inc. filed its 10-Q report for the period ending September 30, 2024. The filing covers the third quarter of 2024, detailing the company's finan
• Labcorp Holdings Inc. Files 8-K on Financials — 8-K · 2024-10-24T00:00:00.000Z [neutral] Risk: low
  Labcorp Holdings Inc. filed an 8-K on October 24, 2024, reporting on its results of operations and financial condition. The filing includes financial statements
• SC 13G/A Filing — SC 13G/A · 2024-10-18T00:00:00.000Z [neutral]
• Labcorp Holdings Files 8-K: Regulation FD & Exhibits — 8-K · 2024-10-10T00:00:00.000Z [neutral] Risk: low
  On October 9, 2024, LABCORP HOLDINGS INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No
• Labcorp Files 8-K: Regulation FD & Exhibits — 8-K · 2024-09-24T00:00:00.000Z [neutral] Risk: low
  Labcorp Holdings Inc. filed an 8-K on September 24, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contai
• Labcorp Holdings Files 8-K Report — 8-K · 2024-09-23T00:00:00.000Z [neutral] Risk: low
  On September 23, 2024, LABCORP HOLDINGS INC. filed an 8-K report. The filing indicates the company entered into a material definitive agreement and also include
• Labcorp Holdings Inc. Files 8-K Report — 8-K · 2024-09-18T00:00:00.000Z [neutral] Risk: low
  On September 16, 2024, LABCORP HOLDINGS INC. filed an 8-K report detailing other events and financial statements. The filing was made public on September 18, 20
• Labcorp Holdings Files 8-K — 8-K · 2024-09-03T00:00:00.000Z [neutral] Risk: low
  On September 3, 2024, LABCORP HOLDINGS INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. N
• Labcorp Files 8-K on Material Agreement and Financial Obligation — 8-K · 2024-08-23T00:00:00.000Z [neutral] Risk: medium
  On August 23, 2024, LABCORP HOLDINGS INC. filed an 8-K report detailing the entry into a material definitive agreement and the creation of a direct financial ob
• Labcorp Holdings Inc. Files Q2 2024 10-Q — 10-Q · 2024-08-02T00:00:00.000Z [neutral] Risk: low
  Labcorp Holdings Inc. filed its 10-Q for the period ending June 30, 2024. The filing includes financial data for the second quarter of 2024, comparing it to the
• Labcorp Holdings Inc. Files 8-K on Financials — 8-K · 2024-08-01T00:00:00.000Z [neutral] Risk: low
  Labcorp Holdings Inc. filed an 8-K on August 1, 2024, reporting on its results of operations and financial condition. The filing includes financial statements a
• Labcorp Files 8-K: Regulation FD Disclosure & Financials — 8-K · 2024-07-25T00:00:00.000Z [neutral] Risk: low
  On July 24, 2024, LABCORP HOLDINGS INC. (Labcorp) filed an 8-K to disclose a Regulation FD event and financial statements. The filing does not contain specific
• Labcorp Holdings Files 8-K Report — 8-K · 2024-07-01T00:00:00.000Z [neutral] Risk: low
  On July 1, 2024, LABCORP HOLDINGS INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No spe
• Labcorp Holdings Files 8-K for Disclosures — 8-K · 2024-06-04T00:00:00.000Z [neutral] Risk: low
  On June 4, 2024, LABCORP HOLDINGS INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No spe
• Labcorp Holdings Files 8-K Report — 8-K · 2024-05-28T00:00:00.000Z [neutral] Risk: low
  On May 28, 2024, LABCORP HOLDINGS INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No spe
• Labcorp Files 8-K on Shareholder Votes — 8-K · 2024-05-16T00:00:00.000Z [neutral] Risk: low
  Laboratory Corporation of America Holdings filed an 8-K on May 16, 2024, reporting on matters submitted to a vote of security holders. The filing date indicates
• Labcorp Files 8-K for Regulatory Disclosure — 8-K · 2024-05-08T00:00:00.000Z [neutral] Risk: low
  Laboratory Corporation of America Holdings (Labcorp) filed an 8-K on May 8, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. Th
• Labcorp Files Q1 2024 10-Q — 10-Q · 2024-04-30T00:00:00.000Z [neutral] Risk: medium
  Laboratory Corporation of America Holdings (Labcorp) filed its 10-Q for the period ending March 31, 2024. The filing details financial performance and operation
• Labcorp Files 8-K on Operations and Financials — 8-K · 2024-04-25T00:00:00.000Z [neutral] Risk: low
  Laboratory Corporation of America Holdings (Labcorp) filed an 8-K on April 25, 2024, to report on its results of operations and financial condition, as well as
• Labcorp Sells Covance for $1.5 Billion — 8-K · 2024-04-11T00:00:00.000Z [neutral] Risk: medium
  Laboratory Corporation of America Holdings (Labcorp) announced on April 10, 2024, that it has entered into a definitive agreement to sell its drug development b
• Labcorp Files DEF 14A: Executive Compensation & Governance — DEF 14A · 2024-04-04T00:00:00.000Z [neutral] Risk: low
  Laboratory Corporation of America Holdings (Labcorp) filed its DEF 14A on April 4, 2024, for the fiscal year ending December 31, 2023. The filing details execut
• Labcorp Files 8-K for Regulatory and Financial Reporting — 8-K · 2024-03-27T00:00:00.000Z [neutral] Risk: low
  Laboratory Corporation of America Holdings (Labcorp) filed an 8-K on March 27, 2024, to report information under Regulation FD and to file financial statements
• LabCorp Files 10-K, Highlights Fortrea Debt & Segment Performance — 10-K · 2024-02-26T00:00:00.000Z [neutral] Risk: medium
  Laboratory Corp of America Holdings filed its 10-K on February 26, 2024, for the fiscal year ending December 31, 2023. The filing details financial information,
• Labcorp Files 8-K on Financial Results and Exhibits — 8-K · 2024-02-15T00:00:00.000Z [neutral] Risk: low
  Laboratory Corporation of America Holdings (Labcorp) filed an 8-K on February 15, 2024, reporting on "Results of Operations and Financial Condition" and "Financ